Log In
Thursday 22nd August 2019

Cannabis chemical to be tested in epilepsy

13th September 2012

A British drug company has unveiled plans to test a compound found in cannabis as a treatment for epilepsy.

The decision by GW Pharmaceuticals follows a promising study by scientists at Reading University using the chemical in rats and mice and could see human clinical trials using cannabidivarin (CBDV) start as early as 2013 after researchers reported the previously little-studied chemical had potential as an anticonvulsant. CBDV is one of many non-psychoactive cannabinoids found in the cannabis plant and does not cause users to feel 'high'.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019